학술논문
Disease activity 4.5 years after starting cladribine: experience in 264 patients with multiple sclerosis.
Document Type
Article
Author
Source
Therapeutic Advances in Neurological Disorders; 11/10/2023, p1-12, 12p
Subject
Language
ISSN
17562856
Abstract
Copyright of Therapeutic Advances in Neurological Disorders is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)